Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

Paused · Phase 1/Phase 2

Conditions studied: Ocular Hypertension, Open Angle Glaucoma

In brief

The aim of this research study is to assess the safety and feasibility of lowering intraocular pressure (IOP) using an experimental study drug, JV-GL1.

Key facts

Study ID

NCT04761705

Run by

JeniVision, Inc.

People needed

70

Starts

2021-03-10

Expected to finish

2025-07-01

Last updated by the study team

2024-05-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• bilateral open-angle glaucoma or ocular hypertension

Where it is running

• Eye Research Foundation — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.